4.2 Article

Silver(I) and Copper(II) 1,10-Phenanthroline-5,6-dione Complexes as Promising Antivirulence Strategy against Leishmania: Focus on Gp63 (Leishmanolysin)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Microbiology

The Anti-Leishmania amazonensis and Anti-Leishmania chagasi Action of Copper(II) and Silver(I) 1,10-Phenanthroline-5,6-dione Coordination Compounds

Simone S. C. Oliveira et al.

Summary: In this study, the effects of silver(I) and copper(II) complexes of 1,10-phenanthroline-5,6-dione (phendione) were evaluated as potential drugs for the treatment of Leishmania infection. The complexes demonstrated significant inhibitory effects on parasite proliferation and induced programmed cell death. They also showed potent activity against intracellular parasites and low toxicity to host cells.

PATHOGENS (2023)

Review Biochemistry & Molecular Biology

Metallopeptidases as Key Virulence Attributes of Clinically Relevant Protozoa: New Discoveries, Perspectives, and Frontiers of Knowledge

Graziela Vargas Rigo et al.

Summary: This article comprehensively reviews the subclasses of metallo-type peptidases expressed by clinically relevant protozoa and their roles in parasitic infections. Metallopeptidases play important roles in key pathophysiological processes and have become valuable targets for finding new chemotherapeutic compounds. The review aims to gather updates on metallopeptidase subclasses and investigate the similarity of peptidase sequences through bioinformatic techniques to discover clusters relevant for developing new antiparasitic molecules.

CURRENT PROTEIN & PEPTIDE SCIENCE (2023)

Review Microbiology

Recent Advances in Chemotherapeutics for Leishmaniasis: Importance of the Cellular Biochemistry of the Parasite and Its Molecular Interaction with the Host

Ranjeet Singh et al.

Summary: Leishmaniasis is a neglected disease caused by Leishmania, transmitted by sand flies. Current treatments have limitations and there is a need to identify new drug targets to improve disease management. This review discusses the use of bioinformatics to target novel drugs and pathways in Leishmania.

PATHOGENS (2023)

Article Nanoscience & Nanotechnology

Surfactant free synthesis of cationic nano-vesicles: A safe triple drug loaded vehicle for the topical treatment of cutaneous leishmaniasis

Sidra Khalid et al.

Summary: This study aimed to develop and evaluate triple drug loaded cationic nano-vesicles (cNVs) for the topical treatment of cutaneous leishmaniasis (CL). The optimized formulation of cNVs showed high entrapment efficiency and reduced irritation potential, demonstrating its potential as an efficient and safe vehicle for the treatment of CL.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2022)

Article Immunology

The Enhanced Expression of Cruzipain-Like Molecules in the Phytoflagellate Phytomonas serpens Recovered From the Invertebrate and Plant Hosts

Simone S. C. Oliveira et al.

Summary: The study found that the phytoflagellate P. serpens expressed cysteine peptidases similar to the virulence factor cruzipain from Trypanosoma cruzi when cultured in complex medium supplemented with tomato extract. Additionally, the expression of cruzipain-like molecules significantly increased when parasites were incubated with dissected salivary glands from insects or recovered from the insects' hemolymph.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Review Immunology

The pathogenicity and virulence of Leishmania-interplay of virulence factors with host defenses

Anand Kumar Gupta et al.

Summary: This review provides an overview of leishmanial virulence factors, their role in immune evasion, and their potential as diagnostic markers. It also discusses the use of immunomodulators as future therapy for leishmaniasis.

VIRULENCE (2022)

Article Biotechnology & Applied Microbiology

Triple-combination therapy for cutaneous leishmaniasis using detergent-free, hyaluronate-coated elastic nanovesicles

Kashif Iqbal et al.

Summary: This study developed and evaluated detergent-free nanovesicles, H-ENVs, for the topical treatment of cutaneous leishmaniasis. The results showed that H-ENVs improved the efficacy of the drugs and could be a safe choice for the treatment of cutaneous leishmaniasis.

NANOMEDICINE (2022)

Article Biochemistry & Molecular Biology

Cathepsin K inhibitors based on 2-amino-1,3,4-oxadiazole derivatives

Talita B. Gontijo et al.

Summary: Two new series of previously unknown dipeptides were synthesized and evaluated as inhibitors of Cathepsin K (Cat K). The oxadiazole derivatives showed potential inhibitory activity, indicating that this scaffold has remarkable potential as a building block for Cat K inhibitors.

BIOORGANIC CHEMISTRY (2021)

Article Immunology

Development of dominant epitope-based vaccines encoding Gp63, Kmp-11 and Amastin against visceral leishmaniasis

Jianhui Zhang et al.

Summary: This study utilized three amino acid fragments of Leishmania parasites as multi-epitope vaccines and used a DNA prime-protein boost strategy for vaccination in BALB/c mice. Evaluation of vaccine immunogenicity and immunoprotection post-challenge showed significant immune effects of the vaccines against Leishmania, especially with nearly 90% parasites reduction rate in the Gp63 group.

IMMUNOBIOLOGY (2021)

Review Immunology

Comparative Analysis of Virulence Mechanisms of Trypanosomatids Pathogenic to Humans

Artur Leonel de Castro Neto et al.

Summary: Trypanosoma brucei, Leishmania spp., and T. cruzi are the causative agents of human African trypanosomiasis, leishmaniasis, and Chagas disease, respectively, and they have developed mechanisms to evade the immune response system throughout the infection cycle, allowing them to survive and propagate in their hosts.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Review Parasitology

Phenotypical and genotypical differences among Leishmania (Leishmania) amazonensis isolates that caused different clinical frames in humans and dogs: A systematic review

Taylon Felipe Silva et al.

Summary: The study revealed that the exact mechanism leading to different clinical manifestations among strains of the same species is still uncertain, and future studies are needed to better elucidate this phenomenon.

ACTA TROPICA (2021)

Review Pharmacology & Pharmacy

Nanotechnology-aided diagnosis, treatment and prevention of leishmaniasis

Olga Kammona et al.

Summary: Leishmaniasis, a prevalent parasitic infection in neglected tropical diseases, lacks efficient diagnostic tools and treatments, posing a serious threat to public health in low- and middle-income countries. Nanotechnology may offer novel approaches to enhance disease detection, therapy, and prevention.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)

Article Parasitology

Anti-Leishmania braziliensis activity of 1,10-phenanthroline-5,6-dione and its Cu(II) and Ag(I) complexes

Ana Karina C. Lima et al.

Summary: Leishmaniasis, a neglected disease caused by parasite Leishmania, lacks an effective vaccine and relies on old drugs with side effects for treatment. A study on inhibitory effects of phendione and its metal complexes on parasite metallopeptidases and motility, as well as their impact on parasite-macrophage interaction, suggests their potential as new drugs against L. braziensis.

PARASITOLOGY RESEARCH (2021)

Review Parasitology

Leishmaniasis: the act of transmission

Tiago D. Serafim et al.

Summary: The contribution of vector transmission to pathogen establishment is underestimated; transmission by sand flies is critical for early survival of Leishmania; recent breakthroughs shed light on factors such as gut microbiota and sand fly immunity affecting transmission of Leishmania.

TRENDS IN PARASITOLOGY (2021)

Review Biotechnology & Applied Microbiology

Recent advances and new strategies on leishmaniasis treatment

Bruno Mendes Roatt et al.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2020)

Review Infectious Diseases

Systematic review on antigens for serodiagnosis of visceral leishmaniasis, with a focus on East Africa

Vera Kuhne et al.

PLOS NEGLECTED TROPICAL DISEASES (2019)

Article Biochemistry & Molecular Biology

Enzyme targets for drug design of new anti-virulence therapeutics

Charlene M. Kahler et al.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2018)

Review Medicine, General & Internal

Leishmaniasis

Sakib Burza et al.

LANCET (2018)

Review Biotechnology & Applied Microbiology

Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance

Seth W. Dickey et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Article Medicine, General & Internal

Leishmaniasis: clinical syndromes and treatment

B. S. McGwire et al.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2014)

Article Biochemistry & Molecular Biology

Antimicrobial Action of Chelating Agents: Repercussions on the Microorganism Development, Virulence and Pathogenesis

A. L.S. Santos et al.

CURRENT MEDICINAL CHEMISTRY (2012)

Review Biochemistry & Molecular Biology

Deciphering the Antimicrobial Activity of Phenanthroline Chelators

M. McCann et al.

CURRENT MEDICINAL CHEMISTRY (2012)

Article Immunology

Leishmania virulence factors: focus on the metalloprotease GP63

Martin Olivier et al.

MICROBES AND INFECTION (2012)

Review Immunology

Impact of Leishmania metalloprotease GP63 on macrophage signaling

Amandine Isnard et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2012)

Article Environmental Sciences

Virulence factors and their mechanisms of action: the view from a damage-response framework

Arturo Casadevall et al.

JOURNAL OF WATER AND HEALTH (2009)

Review Multidisciplinary Sciences

The ubiquitous gp63-like metalloprotease from lower trypanosomatids: in the search for a function

Andre L. S. Santos et al.

ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2006)

Article Chemistry, Medicinal

MolDock: A new technique for high-accuracy molecular docking

Rene Thomsen et al.

JOURNAL OF MEDICINAL CHEMISTRY (2006)

Review Biochemistry & Molecular Biology

The major surface protease (MSP or GP63) of Leishmania sp - Biosynthesis, regulation of expression, and function

CQ Yao et al.

MOLECULAR AND BIOCHEMICAL PARASITOLOGY (2003)